Discovery and Development
Our process shifts the paradigm of drug discovery by integrating biologic wet labs with computational biology, accelerating the validation of new innovative therapeutics.
With a full suite of in-house research and bioanalytical capabilities, we have complete control of our IND- enabling programs.
Our cutting-edge approach integrates methods and process development, cGMP biomanufacturing, and QC release testing to shorten timelines to the clinic.
With an experienced team that understands intelligent and efficient trial design, we focus on identifying the fastest, safest path to patient outcomes and drug approval, advancing the speed of medical innovation.
Clinical samples are irreplaceable. Our capabilities in immunoassays, bioavailability determination, and logistics ensure trusted accuracy, precision, and reliability.
We’ve coupled our cGMP biomanufacturing and quality control expertise with skillful supply chain and cost control management to rapidly advance our programs.